(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | |
---|---|---|---|---|---|---|---|
Turnover | --2.4B | 34.80%5.7B | 52.96%1.25B | 16.12%4.23B | --814.73M | 237.40%3.64B | --1.08B |
Operating income | 2.4B | 34.80%5.7B | 52.96%1.25B | 16.12%4.23B | 814.73M | 237.40%3.64B | 1.08B |
Cost of sales | ---1.64B | -34.77%-3.74B | -52.44%-807.49M | -18.45%-2.78B | ---529.69M | -242.88%-2.34B | ---683.37M |
Operating expenses | -1.64B | -34.77%-3.74B | -52.44%-807.49M | -18.45%-2.78B | -529.69M | -242.88%-2.34B | -683.37M |
Gross profit | 760.06M | 34.86%1.96B | 53.91%438.71M | 11.92%1.46B | 285.04M | 227.94%1.3B | 396.73M |
Selling expenses | ---105.23M | -115.87%-131M | -93.11%-15.83M | -217.30%-60.68M | ---8.2M | -77.43%-19.13M | ---10.78M |
Administrative expenses | ---218.36M | -44.07%-420.45M | -65.00%-87.32M | 18.58%-291.85M | ---52.92M | -446.41%-358.44M | ---65.6M |
Research and development expenses | ---14.52M | -358.45%-16.42M | -473.03%-1.74M | ---3.58M | ---304K | ---- | ---- |
Revaluation surplus | ---145.22M | ---75.84M | ---- | ---- | ---- | ---- | ---- |
-Changes in the fair value of other assets | ---145.22M | ---75.84M | ---- | ---- | ---- | ---- | ---- |
Special items of operating profit | --42.25M | -10.45%49.46M | 112.49%7.71M | 6,322.79%55.24M | --3.63M | 7.90%860K | --797K |
Operating profit | 318.98M | 18.54%1.37B | 50.29%341.52M | 24.99%1.16B | 227.25M | 187.83%924.34M | 321.15M |
Financing cost | ---2.66M | 19.19%-3.69M | 14.51%-978K | -71.00%-4.57M | ---1.14M | -158.41%-2.67M | ---1.03M |
Share of profits of associates | ---6.93M | ---- | ---- | ---- | ---- | ---- | ---- |
Adjustment items of earning before tax | ---- | ---- | ---- | ---- | ---368K | ---- | ---- |
Earning before tax | 309.38M | 18.69%1.37B | 50.86%340.54M | 24.85%1.15B | 225.73M | 187.92%921.67M | 320.11M |
Tax | ---70.75M | -15.64%-215.07M | -51.79%-55.45M | -29.92%-185.99M | ---36.53M | -74.64%-143.15M | ---81.97M |
After-tax profit from continuing operations | 238.63M | 19.28%1.15B | 50.68%285.09M | 23.92%964.76M | 189.2M | 226.91%778.52M | 238.14M |
Earning after tax | 238.63M | 19.28%1.15B | 50.68%285.09M | 23.92%964.76M | 189.2M | 226.91%778.52M | 238.14M |
Minority profit | --1.58M | 10.78%11.57M | 122.25%3.46M | -54.00%10.44M | --1.56M | -39.57%22.7M | --37.57M |
Profit attributable to shareholders | 237.05M | 19.37%1.14B | 50.09%281.64M | 26.26%954.32M | 187.65M | 276.82%755.82M | 200.58M |
Basic earnings per share | 0.178 | 2.83%0.981 | 50.00%0.282 | 25.20%0.954 | 0.188 | 160.07%0.762 | 0.293 |
Diluted earnings per share | 0.177 | 0.981 | |||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | Unqualified Opinion |
Auditor | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | Deloitte Guan Huang Chen Fang Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data